The Role of Radiofrequency Ablation in Benign and Malignant Thyroid Nodules. Surg Clin North Am 2024 Aug;104(4):779-789
Date
06/30/2024Pubmed ID
38944498DOI
10.1016/j.suc.2024.02.007Scopus ID
2-s2.0-85188679006 (requires institutional sign-in at Scopus site) 6 CitationsAbstract
Radiofrequency ablation (RFA) offers a minimally invasive solution for benign, autonomously functioning (AFTN), and malignant thyroid nodules. The technique utilizes high-frequency alternating current to induce coagulative necrosis, effectively destroying target tissue. RFA is performed in the outpatient setting with local anesthesia and sonographic guidance. RFA is effective in producing substantial volume reduction rates in benign nodules and is emerging as a favorable option in AFTN and papillary thyroid microcarcinoma. RFA's advantages include lower complication rates, minimal scarring, and improved quality-of-life outcomes compared to surgery. However, its efficacy in larger and recurrent malignancies requires further investigation.
Author List
Shah M, McManus CAuthor
Catherine McManus MD, MS Associate Professor in the Surgery department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
HumansThyroid Neoplasms
Thyroid Nodule
Treatment Outcome









